Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1978 1
1979 1
1980 2
1981 1
1982 2
1985 1
1988 1
1989 1
1991 1
1993 1
1996 1
2000 1
2001 2
2002 3
2003 9
2004 9
2005 14
2006 11
2007 9
2008 7
2009 2
2010 9
2011 3
2012 5
2013 7
2014 7
2015 7
2016 8
2017 8
2018 6
2019 6
2020 7
2021 1
2022 3
2023 9
2024 11
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
Kwatra SG, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Lynde C, De Bruin-Weller MS, Nahm WK, Sauder M, Gharib R, Barbarot S, Szepietowski JC, Conrad C, Fleischer A, Laquer VT, Misery L, Serra-Baldrich E, Lapeere H, Ahmad F, Jabbar Lopez ZK, Piketty C, Ständer S; OLYMPIA 2 Investigators. Kwatra SG, et al. N Engl J Med. 2023 Oct 26;389(17):1579-1589. doi: 10.1056/NEJMoa2301333. N Engl J Med. 2023. PMID: 37888917 Clinical Trial.
OtezlaTM (Apremilast 30-Mg Tablets).
Abramovits W, Gupta AK, Vincent KD. Abramovits W, et al. Skinmed. 2024 Aug 2;22(3):218-219. eCollection 2024. Skinmed. 2024. PMID: 39090018 Review.
Atopic dermatitis.
Abramovits W. Abramovits W. J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S86-93. doi: 10.1016/j.jaad.2005.04.034. J Am Acad Dermatol. 2005. PMID: 15968268 Review.
YCANTHTM (Cantharidin) Topical Solution.
Gupta AK, Mann A, Vincent K, Abramovits W. Gupta AK, et al. Among authors: abramovits w. Skinmed. 2023 Nov 10;21(5):360-363. eCollection 2023. Skinmed. 2023. PMID: 37945366 Clinical Trial.
OpzeluraTM (Ruxolitinib) Cream 1.5.
Abramovits W, Abraham A, Vincent KD, Gupta AK. Abramovits W, et al. Skinmed. 2024 Sep 17;22(4):288-289. eCollection 2024. Skinmed. 2024. PMID: 39285571
Sulfur/sodium sulfacetamide preparations.
Abramovits W, Kennedy AJ. Abramovits W, et al. Skinmed. 2004 Mar-Apr;3(2):95-101. doi: 10.1111/j.1540-9740.2004.03413.x. Skinmed. 2004. PMID: 15010636 Review. No abstract available.
Light-emitting diode-based therapy.
Abramovits W, Arrazola P, Gupta AK. Abramovits W, et al. Skinmed. 2005 Jan-Feb;4(1):38-41. doi: 10.1111/j.1540-9740.2005.03959.x. Skinmed. 2005. PMID: 15654163 Review. No abstract available.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J; IXORA-R Study Group. Blauvelt A, et al. Br J Dermatol. 2020 Jun;182(6):1348-1358. doi: 10.1111/bjd.18851. Epub 2020 Jan 15. Br J Dermatol. 2020. PMID: 31887225 Free PMC article. Clinical Trial.
Humira (adalimumab).
Abramovits W, Gupta AK. Abramovits W, et al. Skinmed. 2004 May-Jun;3(3):157-9. doi: 10.1111/j.1540-9740.2004.03466.x. Skinmed. 2004. PMID: 15133395 No abstract available.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
178 results